Copyright
©The Author(s) 2025.
World J Gastroenterol. Mar 21, 2025; 31(11): 102795
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.102795
Published online Mar 21, 2025. doi: 10.3748/wjg.v31.i11.102795
Table 3 Factors associated with attenuation coefficient
Characteristic | Univariate analysis | Multivariate analysis | ||||
Coefficient | 95%CI | P value | Coefficient | 95%CI | P value | |
Male gender | 0.040 | -0.006 to 0.087 | 0.090 | |||
Age | -0.005 | -0.007 to -0.003 | < 0.001a | 0 | -0.002 to 0.002 | 0.770 |
BMI | 0.012 | -0.009 to 0.014 | < 0.001a | 0.006 | 0.004 to 0.008 | < 0.001a |
Fasting glucose | 0.017 | 0.006 to 0.027 | 0.002a | 0.004 | -0.003 to 0.012 | 0.250 |
AST | 0 | 0 to 0 | 0.060 | |||
ALT | 0 | 0 to 0 | 0.341 | |||
ALP | 0 | -0.001 to 0 | 0.169 | |||
GGT | 0 | 0 to 0 | 0.946 | |||
TG | 0.016 | 0.009 to 0.024 | < 0.001a | 0.008 | 0.002 to 0.014 | 0.008a |
HDL-C | -0.201 | -0.277 to -0.123 | < 0.001a | -0.024 | -0.088 to 0.040 | 0.462 |
Steatosis grade | 0.134 | 0.116 to 0.151 | < 0.001a | 0.097 | 0.077 to 0.116 | < 0.001a |
Fibrosis stage | 0.040 | 0.018 to 0.063 | < 0.001a | -0.003 | -0.020 to 0.015 | 0.769 |
- Citation: Li XQ, Cheng GW, Akiyama I, Huang XJ, Liang J, Xue LY, Cheng Y, Kudo M, Ding H. Attenuation imaging for hepatic steatosis in chronic hepatitis B vs metabolic dysfunction-associated steatotic liver disease. World J Gastroenterol 2025; 31(11): 102795
- URL: https://www.wjgnet.com/1007-9327/full/v31/i11/102795.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i11.102795